| Model Number |
04541600001 |
| Medical Device Problem Code |
Leak/Splash (1354)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
Patient city: (b)(6) patient country: poland.
|
| |
|
Event or Problem Description
|
|
Reference number (b)(4) event occurred in poland it was reported that, the patient experienced infusion set leakage issue near the region of cannula septum.The issue occured after two days of use.No further information available.
|
| |
|
Event or Problem Description
|
|
To date no additional patient or event details have been received.
|
| |
|
Additional Manufacturer Narrative
|
|
Additional information - this mdr is being submitted to include the below: h6: investigation results under type of investigation, investigation findings, investigation conclusions.H11: investigation summary.The information in this complaint (b)(4) has been evaluated.The batch 5362256 in question was manufactured at (b)(6) site.Investigation process of the complaint was carried out in accordance work instruction (wi) (b)(4) guideline for test of reference samples version 11 for the code idd-pmc02.01 leakage from infusion site (cannula base part/cannula) (specific cause not identified).Complaint investigations.Photo/sample were not provided.In order to test the product, the reference samples from the lot have been requested.The following test was performed: visual test according to work instruction (wi) (b)(4) version 12 on reference samples, 10 samples out 10 samples passed the test.Functional test 1 according to work instruction (wi) (b)(4) version 10 on reference samples, 10 samples out 10 samples passed the test.Functional test 2 according to work instruction (wi) (b)(4) version 7 on reference samples, 10 samples out 10 samples passed the test.A batch record review was conducted resulting in the following: - the lot 5362256 was manufactured according to the device history report (dhr) (b)(4) version 11 on the multivac 10, on 23/aug/2021, with a total of (b)(4) units.-review of the device history report (dhr) showed that all relevant tests required during the related process had been fulfilled and met the requirements.Conclusion summary of the related event: as a result of the following: no reported harm related with the infusion set, no defect on test, no non-conformance (nc) raised during production, no other complaint received on the lot in question this is not related with the issue described, no further actions are required.Therefore, this issue will be monitored through the post marketing surveillance (pms) product trends and malfunction according to the on market quality review (omqr).
|
| |
|
Additional Manufacturer Narrative
|
|
Additional information - this mdr is being submitted to include the below: d9: device available for evaluation has been selected as yes & date returned to mfg was added as well.H6: investigation results under type of investigation, investigation findings, investigation conclusions.H11: investigation summary.The complaint (b)(4) has been evaluated.The lot 5362256 in question was manufactured at the reynosa site.Investigation process of the complaint was carried out in accordance with work instructions (wi) guideline for test of reference.Samples version 12 for the code leakage from infusion site (cannula base part/cannula) (specific cause not identified).Complaint investigations.Photo/sample was not provided.In order to test the product, the reference samples from the lot has been requested.The following test was performed: visual test according to with wi version 12 on reference samples, 10 samples out 10 samples passed the test.Functional test 1 according to wi version 10 on reference samples, 10 samples out 10 samples passed the test.Functional test 2 according to wi version 7 on reference samples, 10 samples out 10 samples passed the test.Batch review the lot 5362256 was manufactured according to the device history record (dhr)t version 11 on the multivac 10, on 23/aug/2021, with a total of (b)(4) units.Review of the dhr showed that all relevant tests required during the related process had been fulfilled and met the requirements.Conclusion summary of the related event.As a result of the following: no reported harm, no defect on test, no non-conformance (nc) raised during production, no other complaint received on the lot in question this is not related with the issue described, no further actions are required.Therefore, this issue will be monitored through the post marketing surveillance (pms) product trends and malfunction according to the on market quality review (omqr) procedure.
|
| |
|
Event or Problem Description
|
|
To date, additional patient or event details were received which have been added in h11.
|
| |
|
Additional Manufacturer Narrative
|
|
Correction: this mdr is being submitted to correct the submitted expiration date under d4.Additional information - this mdr is being submitted to include the below: d9: device available for evaluation has been selected as yes & date returned to mfg was added as well.H6: investigation results under type of investigation.H11: investigation summary.Test results: visual test according to work instruction (wi) version 1.2 used cannulas passed the test.Functional flow test 1 according to wi version 1.2 used cannulas passed the test.Functional leak test 2 according to wi version 1.2 used cannulas passed the test.Trending: as a second review was made on 21/jan/2025 for the trending of complaints and no more complaints have been received from 25/oct/2024 until current date.Conclusion summary of the related event: as a result of the following: no harm reported, no defect on tests returned, no other complaint received on the lot in question and malfunction code, no further actions are required.Therefore, this issue will be monitored through the post market surveillance activities.
|
| |
|
Event or Problem Description
|
|
To date, additional patient or event details were received which have been added in h11.
|
| |
|
Search Alerts/Recalls
|